| Antigen | 19-aa peptide from human MCT4 (1); Designation (#MCT46-P, control/blocking peptide) conjugated to KLH; Epitope location~ C-terminal, Cytoplasmic domain |
| Form | Antiserum Unpurified |
| Product Type | Primary Antibodies |
| SpCrossreactivity | Human MCT46-P sequence is 83% conserved in mouse MCT4. No significant sequence homology exists with other MCTs. For mouse/rat MCT4, we recommend the use of antibody cat # MCT45-S. We also have another antibody that is made to the C-terminal domain of human MCT4 (Cat # MCT45-S). |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |